What is the management of the lethal triad (hypothermia, acidosis, and coagulopathy) in severely injured patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of the Lethal Triad in Severely Injured Patients

The management of the lethal triad (hypothermia, acidosis, and coagulopathy) in severely injured patients requires immediate implementation of damage control surgery, aggressive rewarming strategies, correction of acidosis, and targeted coagulation support to prevent mortality rates that can exceed 80% when these conditions coexist. 1

Understanding the Lethal Triad

  • The lethal triad consists of hypothermia, acidosis, and coagulopathy, which form a synergistic, self-perpetuating cycle that significantly increases mortality in trauma patients 1
  • Hypothermia is defined as core temperature below 35°C and occurs in 1.6-13.3% of injured patients, with temperatures below 34°C associated with mortality rates exceeding 80% 1, 2
  • Acidosis (pH <7.35) progressively worsens clot formation, especially when combined with hypothermia 1
  • Trauma-induced coagulopathy (TIC) occurs in 10-34% of trauma patients and develops through multiple mechanisms including shock, tissue trauma, inflammation, acidemia, hemodilution, massive transfusion, and hypothermia 1, 3

Management Algorithm

1. Immediate Measures

  • Remove wet clothing immediately to prevent evaporative heat loss 4, 5
  • Increase ambient temperature in the trauma bay to 36-37°C 4
  • Apply forced air warming devices and warming blankets 1, 4
  • Administer only warmed intravenous fluids (37-40°C) 1, 4
  • Consider using a hypothermia prevention kit that provides continuous dry heat 1

2. Damage Control Approach

  • Implement damage control surgery in patients with hemorrhagic shock, ongoing bleeding, coagulopathy, hypothermia, or acidosis 1
  • Perform abbreviated surgical procedures focused on controlling hemorrhage and contamination rather than definitive repairs 1
  • Use temporary abdominal closure techniques for further resuscitation in the ICU before definitive repair 1
  • Consider topical hemostatic agents in combination with surgical measures for venous or moderate arterial bleeding associated with parenchymal injuries 1

3. Treating Hypothermia

  • Target normothermia with core temperatures between 36-37°C to create optimal conditions for coagulation 1
  • For severe hypothermia, consider extracorporeal rewarming devices 1
  • Monitor core temperature continuously during resuscitation 4
  • Recognize that a 1°C drop in temperature is associated with approximately 10% drop in coagulation factor function 4

4. Managing Acidosis

  • Correct acidosis through adequate tissue perfusion and oxygenation 1
  • Control bleeding sources to limit ongoing shock and tissue hypoperfusion 1
  • Avoid excessive crystalloid administration which can worsen acidosis through dilution 1, 3
  • Monitor pH, base deficit, and lactate levels to guide resuscitation 3

5. Addressing Coagulopathy

  • Recognize that hypothermia-induced coagulopathy is primarily reversible with rewarming to 37°C, not just administration of clotting factors 4
  • Do not rely solely on standard coagulation tests (PT, PTT) performed at 37°C as they underestimate coagulopathy in hypothermic patients 4
  • Consider thromboelastography (TEG) for point-of-care assessment of coagulation function 3, 2
  • Be aware that there are no survivors reported with an initial INR greater than 3.2 when combined with hypothermia and acidosis 6

Critical Pitfalls to Avoid

  • Do not administer cold intravenous fluids, as they can worsen hypothermia 4
  • Avoid focusing solely on blood product replacement while neglecting temperature management 4
  • Do not delay damage control surgery in patients presenting with the lethal triad 1
  • Recognize that acidosis combined with hypothermia has a synergistic effect on impairing coagulation, while acidosis alone causes minimal change in clot formation 1, 4
  • Avoid excessive crystalloid administration, which can worsen TIC through dilution of clotting factors and inducing hypothermia 1, 3

Monitoring and Reassessment

  • Continuously monitor core temperature, pH, base deficit, and coagulation parameters 3
  • Reassess the patient's response to rewarming and resuscitation efforts 4
  • Consider definitive surgical repair only when target parameters (normothermia, corrected acidosis, improved coagulation) have been achieved 1
  • Be aware that the presence of extreme coagulopathy with concurrent hypothermia and acidosis is associated with extremely poor outcomes 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Severe Coagulopathy: Definition, Pathophysiology, and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hypothermic Coagulopathy Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hypothermia Causes and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Trauma patients with the 'triad of death'.

Emergency medicine journal : EMJ, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.